H-ISAC Report: Hacking Healthcare - TLP White, February 4, 2020

In this edition of Hacking Healthcare, we begin by examining a milestone in the integration of
Artificial Intelligence/Machine Learning (AI/ML) into drug treatment development. Next, we
brief you on new developments in Huawei’s ongoing saga to avoid a European ban and what it
may mean for EU-US relations. Lastly, in continuing our coverage of the cyber insurance
market, we look at what a new decision in favor of an email fraud victim might mean for the
still evolving market.

In this edition:

  • AI Takes Prominent Role in Drug Development
  • Europe and the UK Diverge with the US on Huawei
  • AIG Forced to Cover Cyber Related Losses

Related Resources

Guides/Reports
Public
This edition of Hacking Healthcare,provides an analysis of the coronavirus that tries to cut through the media sensationalism to explore a more nuanced…
Guides/Reports
Public
Ransomware, destructive malware, insider threats, and even honest user mistakes present ongoing threats to organizations. Organizations’ data, such as database…
Guides/Reports
Public
The emergence of artificial intelligence (AI) as a tool for better health care offers unprecedented opportunities to improve patient and clinical team outcomes…
Guides/Reports
Member
    On 06 January 2020, the FBI disseminated the FLASH message “Kwampirs Malware Indicators of Compromise Employed in Ongoing Cyber Supply Chain…
Guides/Reports
Public
Recently, malicious cyber threat actors have been leveraging the current news cycle to launch Coronavirus themed cyberattacks at their targets. Prominent news…
Guides/Reports
Public
National Cyber Awareness System: AA20-031A: Detecting Citrix CVE-2019-19781 01/31/2020 01:07 PM EST   Original release date: January 31, 2020 Summary…